Screener
Eton Pharmaceuticals, Inc. ETON Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | Three months ended / March 31, 2026 | Three months ended / March 31, 2025 |
|---|---|---|
| Cash flows from financing activities | ||
| Proceeds from stock option exercises | 1,389 | 394 |
| Net cash from financing activities | 1,389 | 394 |
| Change in cash and cash equivalents | (6,281) | 2,484 |
| Cash and cash equivalents at beginning of period | 25,942 | 14,936 |
| Cash and cash equivalents at end of period | $19,661 | $17,420 |
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | $881 | $642 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s net change in cash?
- Eton Pharmaceuticals, Inc. (ETON) reported net change in cash of -$6.28M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Eton Pharmaceuticals, Inc.'s net change in cash decreased by 352.9% year-over-year, from $2.48M to -$6.28M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Eton Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude